Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Phase 1 Study of FOR46 in Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03575819
Recruitment Status : Recruiting
First Posted : July 3, 2018
Last Update Posted : August 19, 2021
Sponsor:
Information provided by (Responsible Party):
Fortis Therapeutics, Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : May 31, 2022
Estimated Study Completion Date : September 30, 2022